Literature DB >> 32871799

Long-term Results of Surgery for Colorectal Liver Metastases in Terms of Primary Tumour Location and Clinical Risk Factors.

Vladislav Treska1, Martin Skala2, Kristyna Prochazkova2, Aneta Svejdova2, Tereza Petrakova2, Jakub Sebek2, Ivan Riha2, Jachym Rosendorf2, Robert Polak2, Tomas Skalicky2, Vaclav Liska2.   

Abstract

BACKGROUND/AIM: The aim of the study was to evaluate the influence of primary tumour location and clinical risk factors for long-term results of surgery for colorectal liver metastases (CLMs). PATIENTS AND METHODS: Overall survival (OS) and recurrence-free survival (RFS) were evaluated in 636 patients. Patients were divided by tumour location (right-/left-sided colorectal cancer: RCRC/LCRC; rectal cancer), and age, gender, number and size of CLMs, type of liver surgery and interval from primary operation were evaluated.
RESULTS: One-, 3- and 5-year OS and RFS were independent of primary tumour location (p<0.59). CLM diameter was negatively associated with OS for the whole cohort (p<0.002), and RCRC (p<0.03) and LCRC (p<0.04) groups, as well as for RFS of those with LCRC (p<0.04). CLM number was negatively associated with RFS for the whole cohort (p<0.0001), RCRC (p<0.02), LCRC (p<0.0001) and RC (p<0.02). Radiofrequency ablation and combined procedures led to worse OS for the whole cohort (p<0.03), and to worse RFS for the whole cohort (p<0.0003) and for those with LCRC (p<0.03). A shorter interval between primary colorectal cancer surgery and CLMs procedure was risky for poor OS and RFS of patients with CLMs from RCRC (p<0.05), LCRC (p<0.05) and RC (p<0.02).
CONCLUSION: Primary tumour location together with clinical risk factors are important for long-term results of surgery CLMs. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colorectal carcinoma location; liver metastases; liver surgery; long; risk factors; term results

Mesh:

Year:  2020        PMID: 32871799      PMCID: PMC7652514          DOI: 10.21873/invivo.12087

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  34 in total

1.  Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?

Authors:  Lawrence Lee; Arman Erkan; Noura Alhassan; Justin J Kelly; George J Nassif; Matthew R Albert; John Rt Monson
Journal:  Surg Oncol       Date:  2018-05-29       Impact factor: 3.279

2.  Growth of colorectal liver metastases is not accelerated by intraportal administration of stem cells after portal vein embolization.

Authors:  J Brůha; V Treska; H Mírka; P Hosek; J Fichtl; T Skalický; K Bajcurová; J Ludvík; P Duras; D Lysák; V Liska
Journal:  Rozhl Chir       Date:  2019

3.  Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.

Authors:  Suguru Yamashita; Kristoffer Watten Brudvik; Scott E Kopetz; Dipen Maru; Callisia N Clarke; Guillaume Passot; Claudius Conrad; Yun Shin Chun; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2018-03       Impact factor: 12.969

4.  Relationship between primary colorectal tumour and location of colorectal liver metastases.

Authors:  Samir Pathak; Ebrahim Palkhi; Rajiv Dave; Alan White; Sanjay Pandanaboyana; K Raj Prasad; J Peter A Lodge; Giles J Toogood
Journal:  ANZ J Surg       Date:  2014-07-14       Impact factor: 1.872

Review 5.  Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies.

Authors:  Fausto Petrelli; Michele Ghidini; Sandro Barni; Francesca Steccanella; Giovanni Sgroi; Rodolfo Passalacqua; Gianluca Tomasello
Journal:  Ann Surg Oncol       Date:  2017-03-15       Impact factor: 5.344

6.  Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Authors:  John M Creasy; Eran Sadot; Bas Groot Koerkamp; Joanne F Chou; Mithat Gonen; Nancy E Kemeny; Vinod P Balachandran; T Peter Kingham; Ronald P DeMatteo; Peter J Allen; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  Surgery       Date:  2018-02-15       Impact factor: 3.982

Review 7.  Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.

Authors:  Shanbao Ke; Shufang Zhan; Hongbo Zhu; Danfang Yan
Journal:  J BUON       Date:  2018 Mar-Apr       Impact factor: 2.533

8.  Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

Authors:  Hirofumi Ichida; Yoshihiro Mise; Hiromichi Ito; Takeaki Ishizawa; Yosuke Inoue; Yu Takahashi; Eiji Shinozaki; Kensei Yamaguchi; Akio Saiura
Journal:  World J Surg Oncol       Date:  2019-06-13       Impact factor: 2.754

Review 9.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors.

Authors:  Prashanth Rawla; Tagore Sunkara; Adam Barsouk
Journal:  Prz Gastroenterol       Date:  2019-01-06

10.  Better survival in right-sided versus left-sided stage I - III colon cancer patients.

Authors:  Rene Warschkow; Michael C Sulz; Lukas Marti; Ignazio Tarantino; Bruno M Schmied; Thomas Cerny; Ulrich Güller
Journal:  BMC Cancer       Date:  2016-07-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.